NOMAD POWER SOLUTIONS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$14.37 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2022-03-21
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2020-09-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2020-06-30 was -$285.00, a 102.21% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2020-03-31 was -$14.08K, a 438.43% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2020 was -$14.37K, a 200.00% decline from fiscal 2019.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2019 was $14.37K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month as first filed | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | -$285.00 derived: sum of 3 quarters · filed 2022-03-21 | -$14.37K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$285.00 derived: sum of 2 quarters · filed 2021-11-10 | -$14.37K 10-Q · filed 2021-11-10 | -$2.68K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$285.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$14.37K 10-Q · filed 2021-08-10 | -$2.68K derived: sum of 3 quarters · filed 2021-08-10 | -$17.07K derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$14.08K 10-Q · filed 2021-05-12 | -$2.39K derived: sum of 2 quarters · filed 2021-05-12 | -$16.79K derived: sum of 3 quarters · filed 2021-05-12 | -$3.88K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $11.69K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$2.70K derived: sum of 2 quarters · filed 2021-03-26 | $10.21K derived: sum of 3 quarters · filed 2021-03-26 | $14.37K 10-K · filed 2021-03-26 | |
| 2019-09-30 | -$14.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$1.48K derived: sum of 2 quarters · filed 2020-11-10 | $2.68K 10-Q · filed 2020-11-10 | $21.97K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $12.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $17.07K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $4.16K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |